Sirio Pharma completes acquisition of Best Formulations to advance nutrition and health portfolio

Synergies to bring higher growth and long-term value

Sirio Pharma, a global contract development and manufacturing organisation (CDMO), has completed the acquisition of a majority stake in Best Formulations LLC, a leading contract manufacturer of nutritional supplements and personal care products based in California, US. With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care. 

“Our vision is to become an innovative leader in the field of nutrition and health, and the first choice of our customers”, said Patrick Lin, Chairman and CEO, Sirio, “With the acquisition of Best Formulations both parties are expected to fully leverage synergies through strategic cooperation, including an expanded sales network and other strategic resource sharing. Additionally, through technology and R&D collaboration, joint procurement of raw materials, and production/operational coordination, Sirio expects to further enhance our visibility and competitiveness in the global market and expand market share. This combination will strengthen our ability to help customers expand, accelerate growth and enhance long-term profitability.”

The acquisition of Best Formulations fits into Sirio’s global strategy to bring innovative quality products to customers around the world. By purchasing Best Formulations, Sirio can fully meet the production needs of both international and local brands. Customers will benefit from expanded capacity, global R&D collaboration, local market insights, and diversification of products and services.

Read Previous

Agri-food startups Mallipathra Nutraceutical & Fruvetech among winners of National Startup Awards 2022

Read Next

Singapore to develop seafood products using world’s first unagi cell lines

Leave a Reply